We assessed the correlation between quantitative results of immunological faecal occult blood testing (I-FOBT) and colonic lesions (191 colorectal cancers, 890 adenomas) detected at colonoscopy in 2597 FOBT þ (cutoff 100 ng ml À1 Hb) subjects. At univariate analysis, a higher average faecal Hb content was significantly associated with male gender (P ¼ 0.003), age (P ¼ 0.02), and colonoscopy findings (P ¼ 0.000). Among adenomas, higher faecal Hb content was significantly associated with size (P ¼ 0.0000), presence of severe dysplasia (P ¼ 0.0001), presence of villous component (P ¼ 0.0002), and location in the left colon (P ¼ 0.003). At multivariate analysis adjusting for potential confounders, age (P ¼ 0.03), size (P ¼ 0.0000), and location in the left colon (P ¼ 0.0005) were confirmed as having an independent association with higher faecal Hb content. Immunological FOBT is confirmed to be a specific screening test to detect cancer and adenoma, with a low positivity rate (3.7%) and a high positive predictive value (41.5%). Faecal Hb content is significantly higher for those lesions (cancer and high-risk adenomas) screening is aimed at detecting. British Journal of Cancer (2007) 
Screening by faecal occult blood testing (FOBT) has been shown to be effective in reducing colorectal cancer (CRC) mortality (Mandel et al, 1993; Selby et al, 1993; Saito et al, 1995; Hardcastle et al, 1996; Kronborg et al, 1996; Castiglione et al, 1997; Bertario et al, 1999; Mandel et al, 2000) , and population-based screening is currently recommended by the European Community (Advisory Committee on Cancer Prevention, 2000) and is under implementation in several countries, including Italy (Zorzi et al, 2006) (www. osservatorionazionalescreening.it) .
Screening efficacy was demonstrated for guaiac-based FOBT, but the high diagnostic performance of immunological FOBT assays (I-FOBT) has recently justified their adoption in current screening practice (Saito et al, 1995; Bertario et al, 1999) . The Florence FOBT population-based screening programme, run by the Centro per lo Studio e la Prevenzione Oncologica (CSPO) since 1982, was confirmed to be effective by means of a case -control study : adjusted odds ratio for death from CRC for screened vs not screened subjects was 0.60 (95% CI: 0.4 -0.9). The programme shifted from guaiac to I-FOBT in 1995, after favourable comparison studies with guaiac FOBT (Castiglione et al, 1996 (Castiglione et al, , 2000 and positivity cutoff was set at a 100 ng ml À1 Hb level (Castiglione et al, 2002) . Faecal occult blood testing screening has often been criticised for its limited specificity, Spurious guaiac-based FOBT positivity has not been eliminated with the introduction of I-FOBT, owing to non-neoplastic intestinal bleeding, and the efficacy of FOBT screening has been claimed to be, at least partially, the effect of a large cumulative use of colonoscopy, prompted by spurious FOBT positivity at repeat screening (Lang and Ransohoff, 1994; Ederer et al, 1997) .
The use of quantitative I-FOBT allows for a precise assessment of faecal Hb content and for assessing the association of Hb content to different types of screen-detected colonic lesions. The aim of the present study was to review a large consecutive series of subjects with positive I-FOBT undergoing diagnostic assessment within the Florence screening programme, in order to assess whether I-FOBT positivity is mostly non-neoplastic and just offers a chance for a screening colonoscopy, or if abnormal Hb content is specifically associated to the presence of CRC and high-risk adenomas.
MATERIALS AND METHODS
The study analyses a consecutive series of FOBT þ subjects, invited and complying to diagnostic assessment in the Florence screening programme for colorectal cancer. The detailed features of the screening programme, inviting residents in the 50 -70 years age group to biennial FOBT, have been described elsewhere (Castiglione et al, 1996 (Castiglione et al, , 2000 Zappa et al, 1997) .
A single sampling on a single bowel movement is currently analysed, without any dietary restriction. Immunological faecal occult blood testing used in the study was OC-Hemodia, developed with the OC-Sensor (Eiken Chemical Co, Japan) instrument. The assays is based on the flocculation reaction between human HbA and multiple monoclonal anti-HbA latex-adsorbed antibodies. HbA concentration is measured by reading flocculation as an optical change (increased adsorbance at 660 nm), compared to a standard calibration curve. The inter-series coefficient of variation in our lab was 3.3% (15675.2) at a low and 3.8% at a high (601722.9) Hb level.
The current positivity cutoff prompting diagnostic assessment was 100 ng ml À1 Hb. From December 1996 to September 2005, screened FOBT þ subjects were 3029 of 81 047 (3.73%). Compliance to diagnostic assessment in the study period was 85.7% (2597 of 3029). Assessment was based on total colonoscopy, or on incomplete colonoscopy plus double contrast X-ray for those subjects in whom total colonoscopy was not possible. Subjects with negative colonoscopy were re-invited to screening after 5 years until 2004 and after 10 years thereafter.
Data available for each case were age and gender, quantitative FOBT Hb content (ng ml Àl ), and colonoscopy outcome (cancer, adenoma, other benign lesion, negative). In subjects with multiple findings (e.g. other benign lesions þ adenoma, adenoma þ CRC), only the most severe lesion was considered for the study purpose. Adenomas were further categorised by size (o1, 1 -2, 42 cm), presence/absence of severe dysplasia, histological features (tubular, villous), and site (right/trasverse or left colon): in presence of multiple adenomas, the larger and/or that with the most severe features were considered for the study purpose.
We assessed average FOBT Hb content (ng ml Àl ) by age and gender, by colonoscopy outcome, and according to special conditions (presence of haemorroids, diverticula) which might be associated to non-neoplastic bleeding and were considered separately from colonoscopy outcome. Average FOBT Hb content was also determined by adenoma subcategories.
Differences between observed results were checked by the w 2 test, differences between means were checked by the ). Larger adenomas were observed in the left as compared with right colon (w 2 df ¼ 2 ¼ 6.27, P ¼ 0.04) (data not shown). Apart from colonoscopy outcome, no positive association with higher Hb content was observed for the presence of haemorroids or diverticula. Table 2 shows differences in FOBT Hb content according to adenoma subcategories. A significant positive association was evident for increasing size (P ¼ 0.0000, F ¼ 31.58, df ¼ 2 887), presence of severe dysplasia (P ¼ 0.0001, t ¼ À3.84, df ¼ 888), and presence of villous component (P ¼ 0.0002, t ¼ À3.78, df ¼ 888). Weaker association was recorded for left vs right colon site (P ¼ 0.0037, t ¼ 2.90, df ¼ 877). Table 3 shows multivariate analysis of the association of different patient characteristics and colonoscopy outcome to average FOBT Hb content among subjects with adenoma. A significant association was evident only for adenoma size (P ¼ 0.000) and for localisation in left colon (P ¼ 0.01), and a borderline association was observed for age (P ¼ 0.05). After adjusting for interactions, results did not change. The model was thus limited to variables with significant association, and age (P ¼ 0.03, F ¼ 2.63, df ¼ 4871), size (P ¼ 0.0000, F ¼ 29.29, df ¼ 2, 871), and location in the left colon (P ¼ 0.005, F ¼ 7.76, df ¼ 1871) were confirmed as having an independent association with FOBT Hb content.
DISCUSSION
The present study is based on a relatively large consecutive series, observed within a single population-based screening programme, and followed up according to the same protocol. Immunological-FOBT was based on the same assay over the study period, and processed by a single laboratory: these conditions allow for a reliable estimate of the association of faecal Hb content to the presence of colonic lesions in I-FOBT þ subjects undergoing colonoscopy assessment.
Immunological-FOBT proved to be a rather specific test, with a 41.5% PPV for the presence of CRC or adenoma among assessed subjects, definitely a higher figure as compared to other cancer screening programmes, such as mammographic or cytological screening, where the PPV of a positive screening test does not currently exceed 20%. It is implied that such a high PPV is at least partially due to the exit from screening of bleeders with benign disease undergoing negative colonoscopy, but other reasons, such as a selection of high-risk subjects among screening compliers, cannot be excluded.
Increased faecal Hb content was significantly associated with increasingly severe colonic lesions, confirming previous reports on this subject (Edwards, 2005; Vilkin et al, 2005) . A continuous trend of increasing Hb content was evident, from subjects with negative colonoscopy outcome, to subjects with benign colonic abnormalities other than adenoma, to subjects with adenoma as the most severe lesion, and finally to subjects with CRC. Among subjects with adenoma, faecal Hb content was higher for high-risk subcategories, such as larger size, presence of severe dyplasia or villous component. To our knowledge, this is the first study reporting the association of faecal Hb content to single adenoma characteristics, whereas previous studies grouped adenomas into low-and high-risk categories (Edwards, 2005; Vilkin et al, 2005) . The higher average faecal Hb content recorded for adenomas in the left colon may be likely explained with a higher mechanical action of stool in this section.
Multivariate analysis confirmed an independent and significant association with higher faecal Hb content for patient's age, adenoma location in the left colon, and adenoma size, the latter variable showing the strongest association. This, combined with the association of Hb content with adenoma characteristics, and with the adoption of a 100 ng ml À1 Hb positivity threshold, allowed for a favourable advanced/not advanced adenoma ratio of approximately 3 : 1 (669/221), as compared to approximately 1 : 1 when guaiac FOBT was employed (Castiglione, 1996) .
Immunological-FOBT positivity rate in the present experience was 3.73%. Positivity rate owing to non-neoplastic bleeding is likely to be reduced at repeat screening, as I-FOBT þ colonoscopy negative subjects, who may have a tendency for persistent spurious intestinal bleeding, exit the screening process (for 10 years in the Florence screening programme). Thus, biennial I-FOBT screening from 50 to 70 years of age would imply approximately 20 -30% of screened subjects being I-FOBT þ and Quantitative FOBT and colonic neoplasms S Ciatto et al invited to undergo colonoscopy over a 20 years period. When such figures are compared to a 20% intention-to-screen-based mortality reduction reported by FOBT screening trials, the hypothesis of FOBT screening being effective only through colonoscopies recommended for spurious FOBT positivity is hardly acceptable.
Our findings show that I-FOBT is a specific screening test to detect CRC and adenoma. Immunological-FOBT is associated with a relatively low (3.73%) positivity rate, with a rather high (41.5%) positive predictive value for colonic neoplasms, and faecal Hb content is significantly related to the presence of those lesions (CRC and high-risk adenomas) screening is aimed at detecting.
